Latest filing published 29 Jan 2019 for Aurinia Pharmaceuticals Inc., €20k.
Filing timeline
BuySaleInsider track record
Richard Glickman: trading record in brief
This profile gathers the share dealings of Richard Glickman in Aurinia Pharmaceuticals Inc. The record holds 8 filings, for trades running from 22 June 2016 to 29 January 2019.
On the market, this insider has only ever bought: 4 purchases, €60k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 option exercises. 2019 to date brings 3 purchases and no sales.
In size, the median ticket on the buying side is €17k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 29 January 2019: an open-market purchase of €20k, in Aurinia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard Glickman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,700 shares@ CA$8.102.9% of flowCommon SharesTSXSEDI:3307466Canonical exit: 29 Apr 2019 (T+90)
- 3,100 shares@ CA$8.102.5% of flowCommon SharesTSXSEDI:3307469Canonical exit: 29 Apr 2019 (T+90)
- 1,200 shares@ CA$8.100.9% of flowCommon SharesTSXSEDI:3307468Canonical exit: 29 Apr 2019 (T+90)
- 3,500 shares@ CA$2.1428100.0% of flowCommon SharesTSXSEDI:3280906
- 74,153 shares@ CA$2.7720.2% of flowCommon SharesTSXSEDI:3189157
- 88,889 shares@ CA$2.5021.8% of flowCommon SharesTSXSEDI:3189159
- 3,900 shares@ CA$6.632.5% of flowCommon SharesTSXSEDI:3084591Canonical exit: 15 Feb 2018 (T+90)
- 211,865 shares@ CA$2.3651.0% of flowCommon SharesTSXSEDI:2856592
8 of 8 declarations
